The pH Analysis of Papaverine-Phentolamine and Prostaglandin E 1 for Pharmacologic Erection
- 1 June 1989
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 141 (6) , 1458-1459
- https://doi.org/10.1016/s0022-5347(17)41345-0
Abstract
Although papaverine-phentolamine preparations are being employed for pharmacologic erection programs across the nation, their chemical properties have not been described in the literature. We found that the pH of papaverine-phentolamine solutions in all concentrations tested remained < 4.0. Attempts to buffer the solution resulted in a precipitate at a pH greater than or equal to 5.0. The pH of prostaglandin E1 was < 5.0 but could be easily buffered to pH 7.4 or even 10.75 and remained stable. The effect of an acidic solution on corporal connective tissue and smooth muscle meshwork is unknown. We believe that buffering by blood will lead to the precipitation of papaverine-phentolamine and may cause primary intracorporal scarring. Extravasation or improper injection into the subcutaneous tissue exposes the mixture to blood and may secondarily result in additional scarring for the same reason. Therefore, prostaglandin E1 may be a more appropriate agent for penile injection.This publication has 7 references indexed in Scilit:
- This Month in Investigative Urology: Intracavernosal Injection Therapy for ImpotenceJournal of Urology, 1987
- Effects of Prostaglandin E1 on Penile Erection and Erectile FailureJournal of Urology, 1987
- Physiology of Erection and Pharmacological Management of ImpotenceJournal of Urology, 1987
- Auto-Injection of the Corpus Cavernosum with a Vasoactive Drug Combination for Vasculogenic ImpotenceJournal of Urology, 1985
- Intracavernous Injection of Papaverine as a Diagnostic and Therapeutic Method in Erectile FailureAngiology, 1984
- INTRACAVERNOUS INJECTION OF PAPAVERINE FOR ERECTILE FAILUREThe Lancet, 1982